About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Finerenone
- Company
- Bayer
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 28 recruiting
Efficacy results: Not yet reported
28 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 1, 2026
Find a Clinical Trial Near Me
See recruiting studies for Finerenone and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT02378805
Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
University Hospital Goettingen 800 participants Est. completion 2036-03-01 1 siteOther conditions: Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease, Thin Basement Membrane Disease, Familial Benign HematuriaView official trial listing → -
Recruiting NCT NCT05457283
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Not yet reported Bayer 100 participants Est. completion 2028-08-31 151 sites Stand-aloneChronic kidney disease Other conditions: Proteinuria, ChildrenView official trial listing → -
Recruiting NCT NCT06008197
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Not yet reported Colorado Prevention Center 5200 participants Est. completion 2027-12 356 sites Stand-aloneHeart failureView official trial listing → -
Recruiting NCT NCT06024746
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Not yet reported Colorado Prevention Center 1500 participants Est. completion 2027-11 140 sites Stand-aloneHeart failureView official trial listing → -
Recruiting NCT NCT06033950
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Not yet reported Colorado Prevention Center 2600 participants Est. completion 2028-01 176 sites Stand-aloneHeart failureView official trial listing → -
Recruiting NCT NCT06058585
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Not yet reported The George Institute 1000 participants Est. completion 2029-03-31 43 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Recruiting NCT NCT06059664
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Not yet reported University of North Carolina, Chapel Hill 100 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Recruiting NCT NCT06082063
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 2000 participants Est. completion 2029-07-01 2 sitesCardiovascular diseaseHeart failure Other conditions: Type 1 Diabetes, Kidney FailureView official trial listing → -
Recruiting NCT NCT06143566
Polypill for Prevention of Cardiomyopathy
Not yet reported, Not yet reported University of Texas Southwestern Medical Center 200 participants Est. completion 2027-12-01 1 site Stand-aloneType 2 diabetes Other conditions: High Blood PressureView official trial listing → -
Recruiting NCT NCT06278207
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Bayer 50000 participants Est. completion 2026-09-30 4 sitesChronic kidney diseaseType 2 diabetesView official trial listing → -
Recruiting NCT NCT06573411
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Not yet reported First Affiliated Hospital, Sun Yat-Sen University 116 participants Est. completion 2026-10-30 1 site Stand-aloneOther conditions: Primary Membranous NephropathyView official trial listing → -
Recruiting NCT NCT06655480
Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
Not yet reported National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50 participants Est. completion 2027-12-31 1 site Stand-aloneHeart failure Other conditions: LVDD, Myocardial FibrosisView official trial listing → -
Recruiting NCT NCT06727409
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i as Triple Therapy With Type 2 Diabetes and Chronic Kidney Disease
Not yet reported Chinese University of Hong Kong 82 participants Est. completion 2026-12-31 1 site Stand-aloneType 2 diabetesView official trial listing → -
Recruiting NCT NCT06838416
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Second Affiliated Hospital of Soochow University 300 participants Est. completion 2026-12-31 1 siteType 2 diabetesChronic kidney disease Other conditions: Renal FunctionView official trial listing → -
Recruiting NCT NCT06906081
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Not yet reported Peter Rossing 100 participants Est. completion 2028-01 2 sites Stand-aloneType 2 diabetes Other conditions: Cardiovascular Autonomic Neuropathy, Diabetic NeuropathiesView official trial listing → -
Recruiting NCT NCT07026539
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Not yet reported University of Aarhus 80 participants Est. completion 2028-04-30 1 site Stand-aloneType 2 diabetesChronic kidney diseaseCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07056595
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
Not yet reported Botkin Hospital 30 participants Est. completion 2026-05-21 1 site Stand-aloneOther conditions: IgA Nephropathy (IgAN)View official trial listing → -
Recruiting NCT NCT07188805
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Not yet reported Bayer 111 participants Est. completion 2029-12-30 133 sites Stand-aloneHeart failure Other conditions: Left Ventricular Systolic DysfunctionView official trial listing → -
Recruiting NCT NCT07192952
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Not yet reported Bayer 117 participants Est. completion 2030-12-30 132 sites Stand-aloneHeart failure Other conditions: Left Ventricular Systolic DysfunctionView official trial listing → -
Recruiting NCT NCT07232537
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
Bayer 500 participants Est. completion 2028-01-28 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Recruiting NCT NCT07239570
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Not yet reported Peter Rossing 125 participants Est. completion 2028-06 4 sites Added to GLP-1Chronic kidney diseaseView official trial listing → -
Recruiting NCT NCT07270172
The MICRON Study - A Steno 1 Substudy
University of Aarhus 40 participants Est. completion 2028-12 5 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07315191
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Not yet reported Capital Institute of Pediatrics, China 116 participants Est. completion 2028-04-30 1 site Stand-aloneOther conditions: Henoch Schönlein Purpura NephritisView official trial listing → -
Recruiting NCT NCT07379840
A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
Bayer 300 participants Est. completion 2027-09-30 1 siteHeart failureView official trial listing → -
Recruiting NCT NCT07397650
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Not yet reported Juntendo University 550 participants Est. completion 2028-09-30 21 sites Stand-aloneHeart failureView official trial listing → -
Recruiting NCT NCT07554469
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
Bayer 500 participants Est. completion 2029-04-30 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Recruiting NCT NCT07688928
Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
Not yet reported Bangladesh Medical University 104 participants Est. completion 2027-09 1 site Stand-aloneOther conditions: Primary Aldosteronism, Endocrine HypertensionView official trial listing → -
Recruiting NCT NCT07799519
Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
Not yet reported National Cheng-Kung University Hospital 40 participants Est. completion 2028-08-31 1 site Stand-aloneOther conditions: Atrial Fibrillation (AF)View official trial listing → -
Completed NCT NCT01345656
BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
Not yet reported Bayer 457 participants Est. completion 2012-07-16 50 sitesHeart failureView official trial listing → -
Completed NCT NCT01473108
Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862
Not yet reported Bayer 67 participants Est. completion 2011-05-17 1 site Stand-aloneOther conditions: Clinical PharmacologyView official trial listing → -
Completed NCT NCT01687920
Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets
Not yet reported Bayer 25 participants Est. completion 2013-03-21 1 siteHeart failureView official trial listing → -
Completed NCT NCT01807221
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chronic Kidney Disease Alone
Not yet reported Bayer 1066 participants Est. completion 2014-12-09 172 sites Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01874431
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Not yet reported Bayer 823 participants Est. completion 2014-08-07 147 sites Stand-aloneOther conditions: Diabetic NephropathiesView official trial listing → -
Completed NCT NCT01955694
Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone
Not yet reported Bayer 72 participants Est. completion 2015-02-20 29 sitesHeart failureView official trial listing → -
Completed NCT NCT01968668
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Not yet reported Bayer 96 participants Est. completion 2014-11-07 16 sitesOther conditions: Diabetic NephropathiesView official trial listing → -
Completed NCT NCT02540993
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
Not yet reported Bayer 5734 participants Est. completion 2020-04-14 978 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT02545049
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
Not yet reported Bayer 7352 participants Est. completion 2021-02-02 975 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT02956109
Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Volunteers
Not yet reported Bayer 16 participants Est. completion 2017-03-17 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT02957396
Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects
Not yet reported Bayer 16 participants Est. completion 2017-03-01 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT04435626
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
Not yet reported Bayer 6016 participants Est. completion 2024-06-14 661 sites Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT04477707
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)
Bayer 206 participants Est. completion 2021-06-25 62 sitesOther conditions: Diabetic RetinopathyView official trial listing → -
Completed NCT NCT04795726
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)
Not yet reported Bayer 70 participants Est. completion 2021-06-30 11 sites Stand-aloneOther conditions: Diabetic RetinopathyView official trial listing → -
Completed NCT NCT04881994
A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution
Not yet reported Bayer 27 participants Est. completion 2014-12-08 1 site Stand-aloneHeart failureChronic kidney diseaseView official trial listing → -
Completed NCT NCT04908436
A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution
Not yet reported Bayer 33 participants Est. completion 2012-01-27 1 site Stand-aloneHeart failureChronic kidney diseaseView official trial listing → -
Completed NCT NCT05013008
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants
Not yet reported Bayer 951 participants Est. completion 2021-12-31 115 sites Stand-aloneChronic kidney diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT05047263
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
Not yet reported Bayer 1584 participants Est. completion 2026-02-02 326 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Active, not recruiting NCT NCT05196035
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Not yet reported Bayer 219 participants Est. completion 2027-05-10 132 sites Stand-aloneChronic kidney disease Other conditions: ProteinuriaView official trial listing → -
Completed NCT NCT05254002
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
Not yet reported Bayer 1664 participants Est. completion 2025-03-17 173 sites Stand-aloneType 2 diabetesChronic kidney diseaseView official trial listing → -
Active, not recruiting NCT NCT05348733
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Bayer 4613 participants Est. completion 2026-12-22 56 sitesChronic kidney diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT05526157
An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice
Bayer 50000 participants Est. completion 2024-09-05 5 sitesChronic kidney diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT05552339
A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients
Bayer 348 participants Est. completion 2025-11-18 1 siteType 2 diabetesChronic kidney diseaseView official trial listing → -
Completed NCT NCT05640180
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results
Bayer 17847 participants Est. completion 2023-12-20 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Enrolling by invitation NCT NCT05688579
Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
Not yet reported Nanfang Li 8000 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Hypertension, HyperaldosteronaemiaView official trial listing → -
Completed NCT NCT05703880
An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Bayer 15948 participants Est. completion 2024-10-01 2 sitesChronic kidney diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT05705271
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes Mellitus
Not yet reported Bayer 200 participants Est. completion 2025-07-03 17 sites Stand-aloneChronic kidney diseaseType 2 diabetesView official trial listing → -
Status unknown NCT NCT05814770
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 96 participants Est. completion 2026-03 Stand-aloneOther conditions: Primary Aldosteronism, HypertensionView official trial listing → -
Status unknown NCT NCT05887817
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Not yet reported Saga University 100 participants Est. completion 2026-07-31 1 site Stand-aloneType 2 diabetesChronic kidney diseaseView official trial listing → -
Terminated NCT NCT05897372
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Not yet reported Iain Bressendorff 1 participants Est. completion 2024-09-23 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT05901831
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
Not yet reported Bayer 241 participants Est. completion 2025-09-15 80 sites Stand-aloneChronic kidney disease Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT05924620
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
Not yet reported Chongqing Medical University 60 participants Est. completion 2024-03-12 1 site Stand-aloneOther conditions: Primary AldosteronismView official trial listing → -
Status unknown NCT NCT05974566
Efficacy and Safety of Finerenone in Heart Failure With Reduced Ejection Fraction
Chongqing Medical University 60 participants Est. completion 2023-10-30Heart failure Other conditions: Diabetes Mellitus, Diabetic NephropathiesView official trial listing → -
Completed NCT NCT06094920
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Not yet reported University Medical Center Groningen 12 participants Est. completion 2025-09-24 1 siteType 2 diabetesChronic kidney disease Other conditions: Diabetes Mellitus, Diabetes, Diabetes Complications, AlbuminuriaView official trial listing → -
Status unknown NCT NCT06164379
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Not yet reported Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2024-12-16 1 site Stand-aloneOther conditions: Primary AldosteronismView official trial listing → -
Completed NCT NCT06244758
Finerenone and Renal Oxidative Stress
Not yet reported University of Erlangen-Nürnberg Medical School 91 participants Est. completion 2025-11-25 1 siteOther conditions: Type2diabetesView official trial listing → -
Status unknown NCT NCT06301022
Effectiveness and Safety of Finerenone in Chinese CKD Patients Without Diabetes Mellitus
First Affiliated Hospital of Harbin Medical University 90 participants Est. completion 2024-12-31 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT06381323
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 55 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Primary Aldosteronism, Finerenone, Mineralocorticoid Receptor AntagonistView official trial listing → -
Completed NCT NCT06457074
Finerenone for Patients With Primary Aldosteronism (FAIRY)
Not yet reported Chongqing Medical University 306 participants Est. completion 2026-04-20 1 site Stand-aloneOther conditions: Primary AldosteronismView official trial listing → -
Completed NCT NCT06460987
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245 participants Est. completion 2024-03-31 1 siteOther conditions: Finerenone, IgA Nephropathy, Proteinuria, Safety IssuesView official trial listing → -
Not yet recruiting NCT NCT06580288
Effect of Finerenone in IgA Nephropathy
Not yet reported Zhejiang University 120 participants Est. completion 2026-10-08 Stand-aloneOther conditions: IgA NephropathyView official trial listing → -
Completed NCT NCT06608212
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Bayer 238038 participants Est. completion 2026-06-26 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT06763146
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Practice
Bayer 1200 participants Est. completion 2026-09-30 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Terminated NCT NCT06818305
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
Not yet reported Jinling Hospital, China 10 participants Est. completion 2025-10-01 1 site Stand-aloneChronic kidney disease Other conditions: Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), NephrectomyView official trial listing → -
Completed NCT NCT06835322
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
Not yet reported Alexandria University 100 participants Est. completion 2026-04-01 1 site Stand-aloneOther conditions: GlomerulonephritisView official trial listing → -
Enrolling by invitation NCT NCT06954090
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Not yet reported Steno Diabetes Center Copenhagen 50 participants Est. completion 2027-05-31 1 siteChronic kidney disease Other conditions: Type 2 DM, AlbuminuriaView official trial listing → -
Completed NCT NCT07116512
A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants
Not yet reported Bayer 60 participants Est. completion 2023-07-28 1 site Stand-aloneHeart failure Other conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT07124039
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.
Bayer 6537 participants Est. completion 2026-02-28 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07155694
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Not yet reported Washington D.C. Veterans Affairs Medical Center 30 participants Est. completion 2027-08 1 siteChronic kidney diseaseView official trial listing → -
Enrolling by invitation NCT NCT07181135
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Not yet reported University Medical Center Groningen 180 participants Est. completion 2027-12-31 8 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Withdrawn NCT NCT07223502
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
Not yet reported Sarfez Pharmaceuticals, Inc. Est. completion 2026-09-17 1 siteOther conditions: Hypertension (HTN)View official trial listing → -
Not yet recruiting NCT NCT07235891
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
Not yet reported Alexandria University 40 participants Est. completion 2027-03-20 1 site Stand-aloneChronic kidney disease Other conditions: Retinal Nerve Fiber Layer ThicknessView official trial listing → -
Not yet recruiting NCT NCT07270367
Finerenone and Cardiac Remodeling
Not yet reported Subodh Verma 156 participants Est. completion 2030-12 3 sitesHeart failureView official trial listing → -
Not yet recruiting NCT NCT07326631
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
Not yet reported College of Physicians and Surgeons Pakistan 120 participants Est. completion 2026-07-01 Stand-aloneChronic kidney diseaseHeart failureView official trial listing → -
Active, not recruiting NCT NCT07348718
Rubix LS Diabetic Kidney Disease (DKD) Registry Study
Rubix LS 2000 participants Est. completion 2026-04-01 1 siteChronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07351864
Finerenone Plus SGLT2 Inhibitors in Heart Failure
Not yet reported Mansoura University 60 participants Est. completion 2026-07-31 1 site Stand-aloneHeart failureView official trial listing → -
Active, not recruiting NCT NCT07356388
FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan
Not yet reported kewen Chen,MD 54 participants Est. completion 2028-03-31 1 siteOther conditions: Kidney Transplantation Recipients, Proteinuria PatientsView official trial listing → -
Enrolling by invitation NCT NCT07442448
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
Not yet reported Cathay General Hospital 40 participants Est. completion 2029-12 1 site Stand-aloneHeart failureView official trial listing → -
Not yet recruiting NCT NCT07523867
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Not yet reported Hospital de Messejana Dr. Carlos Alberto Studart Gomes 60 participants Est. completion 2026-11 Stand-aloneHeart failureChronic kidney disease Other conditions: HyperkalemiaView official trial listing → -
Not yet recruiting NCT NCT07537088
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease
Not yet reported First Affiliated Hospital of Wannan Medical College 468 participants Est. completion 2027-07 Added to GLP-1Type 2 diabetesChronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07547878
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07575672
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 2832 participants Est. completion 2029-12-31 61 sites Stand-aloneHeart failure Other conditions: TAVI(Transcatheter Aortic Valve Implantation), FinerenoneView official trial listing → -
Not yet recruiting NCT NCT07583173
Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients
Not yet reported China National Center for Cardiovascular Diseases 104 participants Est. completion 2027-12-31 1 site Stand-aloneHeart failureView official trial listing → -
Not yet recruiting NCT NCT07585526
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.
Not yet reported Institute of Liver and Biliary Sciences, India 160 participants Est. completion 2028-03-31 1 site Stand-aloneMASLDChronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07594145
Precision T1D Platform - New Therapies for Cardio-Renal Complications
Not yet reported Oregon Health and Science University 57 participants Est. completion 2031-12-31 2 sites Stand-aloneHeart failureChronic kidney disease Other conditions: Type 1 Diabetes, Cardio-renal Vascular Function and FailureView official trial listing → -
Not yet recruiting NCT NCT07598864
"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"
Not yet reported Chittagong Medical College 88 participants Est. completion 2027-05-01 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07605390
RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)
Not yet reported Baylor Research Institute 600 participants Est. completion 2028-01 2 sitesChronic kidney diseaseType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07667517
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Not yet reported First Affiliated Hospital of Zhejiang University 148 participants Est. completion 2027-12-31 13 sites Stand-aloneType 2 diabetesChronic kidney disease Other conditions: AlbuminuriaView official trial listing → -
Not yet recruiting NCT NCT07678151
Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
Not yet reported Heart Health Research Center 260 participants Est. completion 2027-08-31 2 sites Stand-aloneOther conditions: Hypertension (HTN)View official trial listing → -
Not yet recruiting NCT NCT07717697
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
First Affiliated Hospital of Chongqing Medical University 425 participants Est. completion 2029-01-30Type 2 diabetesChronic kidney diseaseView official trial listing → -
Completed NCT NCT07719621
Evaluation of the Risk of Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Aeterna Medical Solutions SL 100000 participants Est. completion 2026-08-20 1 siteChronic kidney diseaseType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07775482
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Not yet reported Jean-Maxime Côté 72 participants Est. completion 2030-01 1 site Stand-aloneOther conditions: Acute Kidney Injury, Renal Insufficiency,Chronic, Kidney DiseasesView official trial listing → -
Not yet recruiting NCT NCT07775846
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Not yet reported Huijie Zhang 820 participants Est. completion 2029-06-30 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT07781826
Influence of Neurohormonal Blockade on Natriuresis in Heart Failure Patients
Not yet reported Wroclaw Medical University 80 participants Est. completion 2025-12-31 1 site Stand-aloneHeart failureView official trial listing → -
Not yet recruiting NCT NCT07815509
Finerenone for Premature Ovarian Insufficiency (POI)
Not yet reported The University of Hong Kong-Shenzhen Hospital 46 participants Est. completion 2028-09 1 site Stand-aloneOther conditions: Premature Ovarian InsufficiencyView official trial listing → -
Completed NCT NCT07819227
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide
Not yet reported University Medical Center Groningen 41 participants Est. completion 2026-08-31 6 sites Added to GLP-1Chronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07830940
Finerenone and Cardiac Remodeling in HFpEF
Not yet reported Assiut University 194 participants Est. completion 2028-03-25 Stand-aloneHeart failureView official trial listing → -
Not yet recruiting NCT NCT07841015
A Study to Learn More About How Well Finerenone Works in Real-World in People With Type 2 Diabetes and Chronic Kidney Disease in Primary Care (IMSS= Instituto Mexicano Del Seguro Social)
Bayer 800 participants Est. completion 2027-12-31 1 siteType 2 diabetesChronic kidney diseaseView official trial listing → -
Not yet recruiting NCT NCT07849348
Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria
Not yet reported Peking University People's Hospital 266 participants Est. completion 2027-02 Added to GLP-1Chronic kidney diseaseView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Finerenone, Kerendia, Finerenone (Kerendia, BAY948862)
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.